Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Clinical trial NCT00391846 · COMPLETED

Trial details

NCT number: NCT00391846
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure Ventricular Dysfunction, Left

Start date: 2006-10-01
Primary completion: 2009-01-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.